RAPT Therapeutics, Inc. (RAPT) Financials
RAPT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 173.3 million | 26.3 million |
2023-09-30 | 199.7 million | 26.9 million |
2023-06-30 | 220.8 million | 21.1 million |
2023-03-31 | 248.3 million | 27.9 million |
RAPT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -27.8 million | 4.4 million |
2023-09-30 | -22.0 million | 4.3 million |
2023-06-30 | -29.0 million | 4.2 million |
2023-03-31 | -19.4 million | 4.1 million |
RAPT Net Income
No data available :(
RAPT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 158.9 million | - | 6.9 million |
2023-09-30 | 184.8 million | - | 7.5 million |
2023-06-30 | 205.0 million | - | 8.0 million |
2023-03-31 | 231.6 million | - | 8.5 million |
RAPT Shares Outstanding
RAPT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 67000 | 26.8 million | 6.5 million | -323000 |
2023-09-30 | 66000 | 27.0 million | 6.9 million | - |
2023-06-30 | 233000 | 21.6 million | 6.7 million | - |
2023-03-31 | 759000 | 25.6 million | 6.0 million | - |
RAPT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 323000 |
2023-09-30 | - | 908000 |
2023-06-30 | - | 853000 |
2023-03-31 | - | 883000 |
RAPT
Price: $8.18
52 week price:
Earnings Per Share: -3.05 USD
P/E Ratio: -9.06
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 309600
Market Capitalization: 278.7 million